The biopharmaceutical landscape is undergoing a monumental shift toward advanced therapies, positioning the Cell Banking Outsourcing Market as a critical infrastructure pillar. Valued at USD 13.66 billion in 2024, the market is projected to skyrocket to USD 39.26 billion by 2032, expanding at a remarkable compound annual growth rate (CAGR) of 14.10%. https://www.databridgemarketresearch.com/